Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence

Biologics against tumor necrosis factor (anti-TNF) have dramatically changed the management of moderate-to-severe ulcerative colitis (UC). In pivotal clinical trials, golimumab showed efficacy as induction and maintenance therapy in anti-TNF naïve UC patients. However, confirmatory data on effectiveness in the real world setting are needed.

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2QKsInL
via IFTTT